This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J (1996) Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153: 592–606
American Psychiatric Association (1993) Practice guideline for major depressive disorder in adults. Am J Psychiatry 150 (suppl.): 1–26
Baumann P, Rochat B (1995) Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. Int Clin Psychopharmacol to (suppl. 1 ): 15–21
Benkert O, Hippius H (1996) Psychiatrische Pharmakotherapie (6. Auflage). Springer, Berlin Bezchlibnyk-Butler KZ, Jeffries JJ (1996) Clinical handbook of psychotropic drugs ( 6th edition ). Hogrefe & Huber Publishers, Seattle
Brunello N, Burrows GD, Jönsson CPB, Judd LL, Kasper S, Keller MB, Kupfer DJ, Lecrubier Y, Mendlewicz J, Montgomery SA, Nemeroff CB, Preskorn S, Racagni G, Rush AJ (1995) Critical issues in the treatment of affective disorders. Depression 3: 187–198
Ciraulo DA, Shader RI (1990) Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics. J Clin Psychopharmacol lo: 48–50
Ciraulo DA, Shader RI, Greenblatt DJ, Creelman W (1995) Drug Interactions in Psychiatry ( Second Edition ). Williams & Wilkins, Baltimore
Dilsaver SC (1988) Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology. Acta Psychiatr Scand 78: 1–7
Drake WM, Gordon GD (1994) Complete heart block in a patient on propranolol and fluoxetine. Lancet 343: 425–426
Feighner JP (1994) The role of venlafaxine in rational antidepressant therapy. J Clin Psychiatry 55 (9, suppl. A): 62–68
Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ (1990) Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatr 47: 1093–1099
Hiemke C, Weigmann H, Härtter S, Dahmen N, Wetzel H, Müller H (1994) Elevated levels of clozapine in serum after the addition of fluvoxamine. J Clin Psychopharmacol 14: 279–281
Jenkins SC, Hansen MR (1995) A Pocket Reference for Psychiatrists ( Second Edition ). American Psychiatric Press, Washington
Kasper S, Kasper A (1994) Langzeitbehandlung affektiver Störungen. Nervenarzt 65: 577–589
Kasper S, Tauscher J (1996) Neue Entwicklungen bei der psychopharmakologischen Behandlung. Nervenheilkunde 15: 56–62
Keller MB (1988) Undertreatment of major depression. Psychopharmacol Bull 24: 75–80
Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RMA (1986) The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective followup. Am J Psychiatry 143: 24–28
Ketter TA, Flockhart DA, Post RM, Denicoff K, Pazzaglia PJ, Marangell LB, George MS, Callahan AM (1995) The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 15: 387–398
Kupfer DJ (1993) Management of recurrent depression. J Clin Psychiatry 54: (2, suppl.) 29–33 Leonard BE (1993) The comparative pharmacology of new antidepressants. J Clin Psychiatry 54 (8, suppl.): 3–15
Leonard BE (1995) Mechanisms of action of antidepressants. CNS Drugs 4 (suppl. 1): 1–12
Nemeroff CB (1994) Evolutionary trends in the pharmacotherapeutic management of depression. J Clin Psychiatry 55 (12, suppl.): 3–15
Nemeroff CB, de Vane CL, Pollock BG (1996) Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153: 311–320
Nierenberg A, Feighner JP, Rudolph R, Cole J, O’Sullivan J (1994) Venlafaxine for treatment-resistant depression. J Clin Psychopharmacol 14: 419–423
Preskorn SH (1989) Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry 5o (7, suppl.): 34–42
Richelson E (1994) The pharmacology of antidepressants at the synapse: Focus on newer compounds. J Clin Psychiatry 55 (9, suppl.): 34–39
Rudorfer MV, Potter WZ (1989) The new generation of antidepressants. In: Extein IL (ed) Treatment of tricyclic-resistant depression, American psychiatric press, Washington, pp. 83–134
Schatzberg A, Nemeroff CB (1995) Textbook of Psychopharmacology. The American Psychiatric Press, Washington
Sitsen JMA, Zivkov M (1995) Mirtazapine: Clinical profile. CNS Drugs 4 (Suppl. 1): 39–48
Trimble MR (1996) Biological Psychiatry. Wiley & Sons, Chichester Walley T, Pirmohamed M, Proudlove C, Maxwell D (1993) Interaction of metoprolol and fluoxetine. Lancet 341: 967–968
Wetzel H (1995) Klinische Beurteilung von Antidepressiva-and Neuroleptikablutspiegeln. Psychopharmakotherapie 3: 131–134
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bauer, M., Berghöfer, A. (1997). Leitlinien und praktische Durchführung der Pharmakotherapie mit Antidepressiva. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-10500-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61675-7
Online ISBN: 978-3-662-10500-9
eBook Packages: Springer Book Archive